Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- Resource Type
- Article
- Source
- In
Oral Oncology December 2023 147 - Subject
- Language
- ISSN
- 1368-8375